Search clinical trials for: Velcade (Bortezomib)
Total 958 results
-
Jin Lu, MDRecruiting
-
PfizerCompletedMultiple MyelomaUnited States, Germany, Czech Republic
-
Charite University, Berlin, GermanyEuropean Organisation for Research and Treatment of Cancer - EORTC; Centre... and other collaboratorsRecruitingAcute Lymphoblastic Leukemia (ALL)United Kingdom, Australia, Austria, Belgium, Czechia, Denmark, Finland, France, Israel, Italy, Netherlands, Norway, Poland, Portugal, Sweden
-
University Hospital, Clermont-FerrandCompletedMultiple Myeloma | Chemotherapy Induced Peripheral NeuropathyFrance
-
SanofiCompleted
-
University of Michigan Rogel Cancer CenterCompletedMultiple MyelomaUnited States, Canada
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CephalonCompleted
-
Bristol-Myers SquibbTerminatedMultiple MyelomaUnited States, Italy, France, Spain
-
Bristol-Myers SquibbExelixisCompletedAdvanced Cancer, Various, NOSUnited States
-
PETHEMA FoundationCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedTumors | Non-Hodgkins's LymphomaUnited States
-
Hamid SayarBayer; Merck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.Completed
-
University of Southern CaliforniaUnknownRenal Cell CancerUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.Terminated
-
Novartis PharmaceuticalsCompletedMultiple MyelomaChina, United States, Italy, Taiwan, Egypt, Japan, Turkey, Germany, Netherlands, Canada, Australia, Austria, Israel, Sweden, United Kingdom, Korea, Republic of, Spain, Hong Kong, Thailand, France, Belgium, Norway, South Africa, Brazil, ... and more
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaAustria, Greece, Italy, Netherlands, Germany
-
University of Heidelberg Medical CenterActive, not recruiting
-
University Health Network, TorontoAstellas Pharma Inc; Multiple Myeloma Research ConsortiumTerminatedMultiple MyelomaUnited States, Canada
-
Dana-Farber Cancer InstituteCompletedLymphoma | Leukemia | Myelodysplastic SyndromeUnited States
-
University of MiamiWithdrawnMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
University Hospital of CreteCompletedNon Small Cell Lung Cancer | MetastaticGreece
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphoma | Mantle Cell LymphomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMultiple Myeloma | Chronic Myeloid Leukemia (CML) | Pancreatic Ca | Colon/Rectal Ca | Carcinoma, Non-Small -Cell LungUnited States
-
NanoAlvandCompletedMultiple Myeloma, Refractory
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Janssen-Cilag G.m.b.HCompletedMultiple MyelomaGermany
-
Groupe Francophone des MyelodysplasiesUnknownMyelodysplastic SyndromesFrance
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
University of ArkansasMillennium Pharmaceuticals, Inc.Active, not recruitingMultiple MyelomaUnited States
-
University of Texas Southwestern Medical CenterParkland Health and Hospital SystemWithdrawnDiabetes | Diabetes Complications | Wound Infection | Diabetic Foot UlcerUnited States
-
GlaxoSmithKlineWithdrawn
-
AHS Cancer Control AlbertaAbbott; Tom Baker Cancer CentreCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation (M1) | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities and other conditionsUnited States, Canada, Australia
-
Prof. Dr. M. Dreyling (co-chairman)ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...UnknownMantle Cell LymphomaFrance, Germany
-
Mayo ClinicCompletedPrimary Systemic AmyloidosisUnited States
-
Janssen Research & Development, LLCCompletedMultiple MyelomaKorea, Republic of, Malaysia, China, Taiwan, Hong Kong
-
University of Heidelberg Medical CenterCompleted
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
University of ChicagoRecruiting
-
Boston Medical CenterMillennium Pharmaceuticals, Inc.Completed
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
University of ArkansasWithdrawn
-
University of ChicagoNational Cancer Institute (NCI)Completed
-
Jazz PharmaceuticalsRecruitingPregnancy | Pregnancy Complication | Maternal Complications | Birth Outcomes, AdverseUnited States
-
Hospital General de MexicoRecruitingAcute Lymphoblastic Leukemia, in Relapse | Chemotherapeutic Toxicity | Minimal Residual DiseaseMexico
-
PETHEMA FoundationCompleted